Summary by Moomoo AI
Teladoc Health has filed a DEFA14A proxy statement with the United States Securities and Exchange Commission (SEC) in Washington, D.C. The filing, which is pursuant to Section 14(a) of the SEC regulations, is a preparatory step for upcoming corporate actions that require shareholder votes. Proxy statements are typically filed ahead of annual meetings where shareholders vote on various company matters, including the election of directors, executive compensation, and other significant corporate governance issues. The exact date of the meeting and the matters to be voted on have not been specified in the announcement.